Tamatam Anand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tamatam Anand has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Farhath Khanum
DFRL, DRDO, Mysore
18 shared publications- Mirazkar Dasharatharao Pandareesh
Biochemistry and Nanosciences Discipline, Defence Food Research Laboratory, Siddarthanagar, Mysore, 570011, India
11 shared publications Pratiksha V. Bhat
Nutrition, Biochemistry and Toxicology Division, Defence Food Research Laboratory, Mysuru, India
5 shared publicationsN. Ilaiyaraja
4 shared publicationsG. R. Sharath Babu
Nutrition, Biochemistry and Toxicology Division, Defence Food Research Laboratory, Mysuru, India
3 shared publicationsIlaiyaraja Nallamuthu
Nutrition, Biochemistry and Toxicology Division, Defence Institute of Bio-Defence Technology (DIBT-DRDO), Siddhartha Nagar, Mysore 570011, India
3 shared publications
Latest Publications
- 23 September 2024
- Published by Springer Nature in Food Analytical Methods
- Vol. 17 (12) , 1702-1713
Analysis of Vitamin D3 in Meat-Based Ready-To-Eat (RTE) Products: A Comparative Study of Extraction Methods (SPE and DLLME) Using LC–MS/MS
- 23 September 2024
- Published by Springer Nature in Food Analytical Methods
- Vol. 17 (12) , 1702-1713
Analysis of Vitamin D3 in Meat-Based Ready-To-Eat (RTE) Products: A Comparative Study of Extraction Methods (SPE and DLLME) Using LC–MS/MS
- Open Access
Folic acid-loaded chitosan nanoparticles: Cytotoxicity, acute and sub-acute oral toxicity and bioavailability in Wistar rats
The study aims to develop folic acid-loaded chitosan nanoparticles (FA-Chi-NPs) as the vitamin is sensitive to heat and light and to investigate the safety of FA-Chi-NPs in vitro and in vivo . The prepared formulation showed an average diameter of 191.7 ± 2 nm with a zeta potential of + 52 ± 4 mV and PDI of 0.195 ± 0.03. The encapsulation efficiency was found to be 80%. In vitro cytotoxicity assays revealed that FA-Chi-NPs had no cytotoxic effect on Caco-2 cells. Acute-toxicity and subacute-toxicity of FA-Chi-NPs (0.4, 2, and 4 mg/kg body weight) revealed no mortality, and no gross morphological abnormalities were noticed. There were no dose-dependent toxic effects of free folic acid (FA) and FA-Chi-NPs in haematological, histological, plasma biochemical indices, oxidative stress enzymes, or other parameters when compared to the control group(s). The plasma and tissue levels of FA from FA-Chi-NPs were significantly higher. Results demonstrated enhanced bioavailability of FA from FA-Chi-NPs with no toxicity. Practical applications: In the current study, nanoencapsulation is used as a potential approach to enhance folic acid bioavailability. The results showed that encapsulating folic acid in chitosan improved bioavailability with no apparent adverse effects, and thus chitosan could be a promising polymer for safe folic acid delivery.
Open AccessFolic acid-loaded chitosan nanoparticles: Cytotoxicity, acute and sub-acute oral toxicity and bioavailability in Wistar rats
The study aims to develop folic acid-loaded chitosan nanoparticles (FA-Chi-NPs) as the vitamin is sensitive to heat and light and to investigate the safety of FA-Chi-NPs in vitro and in vivo . The prepared formulation showed an average diameter of 191.7 ± 2 nm with a zeta potential of + 52 ± 4 mV and PDI of 0.195 ± 0.03. The encapsulation efficiency was found to be 80%. In vitro cytotoxicity assays revealed that FA-Chi-NPs had no cytotoxic effect on Caco-2 cells. Acute-toxicity and subacute-toxicity of FA-Chi-NPs (0.4, 2, and 4 mg/kg body weight) revealed no mortality, and no gross morphological abnormalities were noticed. There were no dose-dependent toxic effects of free folic acid (FA) and FA-Chi-NPs in haematological, histological, plasma biochemical indices, oxidative stress enzymes, or other parameters when compared to the control group(s). The plasma and tissue levels of FA from FA-Chi-NPs were significantly higher. Results demonstrated enhanced bioavailability of FA from FA-Chi-NPs with no toxicity. Practical applications: In the current study, nanoencapsulation is used as a potential approach to enhance folic acid bioavailability. The results showed that encapsulating folic acid in chitosan improved bioavailability with no apparent adverse effects, and thus chitosan could be a promising polymer for safe folic acid delivery.
- 27 April 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (3) , 395-409
Mucuna pruriens Seed Extract: a Possible Protective Agent Against Ochratoxin A Neurodegeneration
- 27 April 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (3) , 395-409
Mucuna pruriens Seed Extract: a Possible Protective Agent Against Ochratoxin A Neurodegeneration
- 29 March 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (7) , e14158
Comparative evaluation of Brassica oleracea , Ocimum basilicum , and Moringa oleifera leaf extracts on lipase inhibition and adipogenesis in 3T3‐L1 adipocytes
The anti-adipogenic effects of alcohol extract of Brassica oleracea (BO), Ocimum basilicum (OB), and Moringa oleifera (MO) leaves on 3T3-L1 pre-adipocyte as well as their lipase inhibitory properties were comparatively evaluated. The polyphenol-rich extracts of MO, BO, and OB leaves were profiled for major bioactive compounds using UPLC-HRMS/MS analysis. Among the three plant extracts, BO had the highest flavonoid content with stronger radical scavenging activity. All extracts exhibited lipase inhibitory activities, dose-dependently and a non-competitive type of inhibition with altered kinetic parameters was observed. In cell culture studies, these plant extracts remarkably inhibited the intracellular triglyceride accumulation in 3T3-L1 cells and the effect was in the decreasing order of BO > OB > MO. The extracts also down-regulated the key transcription factors of adipogenesis (PPARγ, C/EPB-α, PI3k, p-Akt, and FAS enzyme) as well as modulated the release profile of leptin and adiponectins. Overall, BO extract showed an exceptional inhibitory potential against both adipogenesis and lipase activities among the evaluated plants. PRACTICAL APPLICATIONS: The present study highlights the anti-adipogenic potential of three local edible plants and herbs, that is, Brassica oleracea (BO), Ocimum basilicum (OB), and Moringa oleifera (MO) leaves, using in vitro models. The results revealed that the BO extract had remarkable activity against adipogenesis in the 3T3-L1 pre-adipocyte differentiation model as well as lipase inhibitory properties. This study elucidates the prospects of natural plant-derived compounds in managing obesity-related health issues. The outcomes of this study would be useful in developing alternative or complementary therapies that are being preferred and largely sought over pharmacological treatments and procedures for controlling and treating abnormal weight gain in humans.
- 29 March 2022
- Published by Wiley in Journal of Food Biochemistry
- Vol. 46 (7) , e14158
Comparative evaluation of Brassica oleracea , Ocimum basilicum , and Moringa oleifera leaf extracts on lipase inhibition and adipogenesis in 3T3‐L1 adipocytes
The anti-adipogenic effects of alcohol extract of Brassica oleracea (BO), Ocimum basilicum (OB), and Moringa oleifera (MO) leaves on 3T3-L1 pre-adipocyte as well as their lipase inhibitory properties were comparatively evaluated. The polyphenol-rich extracts of MO, BO, and OB leaves were profiled for major bioactive compounds using UPLC-HRMS/MS analysis. Among the three plant extracts, BO had the highest flavonoid content with stronger radical scavenging activity. All extracts exhibited lipase inhibitory activities, dose-dependently and a non-competitive type of inhibition with altered kinetic parameters was observed. In cell culture studies, these plant extracts remarkably inhibited the intracellular triglyceride accumulation in 3T3-L1 cells and the effect was in the decreasing order of BO > OB > MO. The extracts also down-regulated the key transcription factors of adipogenesis (PPARγ, C/EPB-α, PI3k, p-Akt, and FAS enzyme) as well as modulated the release profile of leptin and adiponectins. Overall, BO extract showed an exceptional inhibitory potential against both adipogenesis and lipase activities among the evaluated plants. PRACTICAL APPLICATIONS: The present study highlights the anti-adipogenic potential of three local edible plants and herbs, that is, Brassica oleracea (BO), Ocimum basilicum (OB), and Moringa oleifera (MO) leaves, using in vitro models. The results revealed that the BO extract had remarkable activity against adipogenesis in the 3T3-L1 pre-adipocyte differentiation model as well as lipase inhibitory properties. This study elucidates the prospects of natural plant-derived compounds in managing obesity-related health issues. The outcomes of this study would be useful in developing alternative or complementary therapies that are being preferred and largely sought over pharmacological treatments and procedures for controlling and treating abnormal weight gain in humans.
- 12 March 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 208, 596-610
Enhanced cellular uptake, transport and oral bioavailability of optimized folic acid-loaded chitosan nanoparticles
- 12 March 2022
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 208, 596-610
Enhanced cellular uptake, transport and oral bioavailability of optimized folic acid-loaded chitosan nanoparticles
- 9 July 2021
- Published by Wiley in Journal of Food Biochemistry
- Vol. 45 (8) , e13863
Menthol, a bioactive constituent of Mentha , attenuates motion sickness in mice model: Involvement of dopaminergic system
Motion sickness (MS) occurs due to contradicting vestibular and visual inputs to the brain causing nausea and vomiting. Antidopaminergic drugs being effective in reducing MS create a path for effective therapy against MS by regulating dopamine levels. We aimed to evaluate the role of the striatum and brainstem dopamine and dopamine D2 receptor (DRD2) in MS and the efficacy of menthol (MNT) to modulate dopamine and DRD2 in vitro and in vivo for possible amelioration of MS. Evaluation of efficacy of MNT to inhibit dopamine release from PC12 cells and anti-MS efficacy in BALB/c mice model was performed. Dopamine, DRD2 expression in PC12 cells, mice striatum, and brainstem were detected using HPLC-ECD, RT-PCR, and Western blot analysis, respectively. DRD2 expression increased in calcium ionophore-treated PC12 cells compared with control cells. Pretreatment with 50 μg/ml menthol decreased dopamine and DRD2 expression. Similarly, dopamine and DRD2 levels in mice striatum and brainstem of MS group (rotation induced) increased significantly compared with control group NC (no rotation). Pretreatment with menthol at 50 mg/kg concentration (rotation induced) showed decreased dopamine and DRD2 expression, thus indicating ameliorative effect on MS. Hence, we suggest that increased striatum and brainstem dopamine and DRD2 levels might lead to MS symptoms, and menthol could be used as a potent herbal alternative medicine for MS. Practical applications Antidopaminergic drugs being effective in reducing motion sickness (MS) creates a path for effective therapy against MS by regulating dopamine levels. Increased striatum and brainstem dopamine and Dopamine D2 receptor (DRD2) levels might lead to the MS symptoms induced by rotation stimulation in mice model. Menthol showed a prophylactic effect on rotation-induced MS by reducing striatal and brainstem dopamine levels, DRD2 mRNA, and protein expression. Menthol could be used as an herbal alternative to antidopaminergics to minimize the associated adverse effects.
- 9 July 2021
- Published by Wiley in Journal of Food Biochemistry
- Vol. 45 (8) , e13863
Menthol, a bioactive constituent of Mentha , attenuates motion sickness in mice model: Involvement of dopaminergic system
Motion sickness (MS) occurs due to contradicting vestibular and visual inputs to the brain causing nausea and vomiting. Antidopaminergic drugs being effective in reducing MS create a path for effective therapy against MS by regulating dopamine levels. We aimed to evaluate the role of the striatum and brainstem dopamine and dopamine D2 receptor (DRD2) in MS and the efficacy of menthol (MNT) to modulate dopamine and DRD2 in vitro and in vivo for possible amelioration of MS. Evaluation of efficacy of MNT to inhibit dopamine release from PC12 cells and anti-MS efficacy in BALB/c mice model was performed. Dopamine, DRD2 expression in PC12 cells, mice striatum, and brainstem were detected using HPLC-ECD, RT-PCR, and Western blot analysis, respectively. DRD2 expression increased in calcium ionophore-treated PC12 cells compared with control cells. Pretreatment with 50 μg/ml menthol decreased dopamine and DRD2 expression. Similarly, dopamine and DRD2 levels in mice striatum and brainstem of MS group (rotation induced) increased significantly compared with control group NC (no rotation). Pretreatment with menthol at 50 mg/kg concentration (rotation induced) showed decreased dopamine and DRD2 expression, thus indicating ameliorative effect on MS. Hence, we suggest that increased striatum and brainstem dopamine and DRD2 levels might lead to MS symptoms, and menthol could be used as a potent herbal alternative medicine for MS. Practical applications Antidopaminergic drugs being effective in reducing motion sickness (MS) creates a path for effective therapy against MS by regulating dopamine levels. Increased striatum and brainstem dopamine and Dopamine D2 receptor (DRD2) levels might lead to the MS symptoms induced by rotation stimulation in mice model. Menthol showed a prophylactic effect on rotation-induced MS by reducing striatal and brainstem dopamine levels, DRD2 mRNA, and protein expression. Menthol could be used as an herbal alternative to antidopaminergics to minimize the associated adverse effects.
- Open Access
- 18 June 2020
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 90 (5) , 1101-1112
Terminalia arjuna Extract Attenuates Isoproterenol-Induced Cardiac Stress in Wistar Rats via an Anti-Apoptotic Pathway
- 18 June 2020
- Published by Springer Nature in Proceedings of the National Academy of Sciences, India Section B: Biological Sciences
- Vol. 90 (5) , 1101-1112
Open AccessTerminalia arjuna Extract Attenuates Isoproterenol-Induced Cardiac Stress in Wistar Rats via an Anti-Apoptotic Pathway
- 1 February 2020
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 84, 107163
In-silico therapeutic investigations of arjunic acid and arjungenin as an FXR agonist and validation in 3T3-L1 adipocytes
- 1 February 2020
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 84, 107163
In-silico therapeutic investigations of arjunic acid and arjungenin as an FXR agonist and validation in 3T3-L1 adipocytes